FOI 7402 - Patients treated with various drugs for migraine

Date: 17 June 2022 to 17 June 2025

Could you please tell me how many patients have been treated in the past 4 months with the following drugs:

  • Erenumab (Aimovig) – for any disease
  • Fremanezumab (Ajovy) – for any disease
  • Galcanezumab (Emgality) – for any disease
  • Botulinum Toxin (i.e., Botox, Dysport, Xeomin) – for migraine ONLY
  • Request ID:
    7402
  • Category:
    Patient - Activity Data
  • Response:

    June 2022

    Freedom of Information Request: reference 7402

     

    Thank you for your recent request under the Freedom of Information Act 2000.

     

    The information you have requested is as follows:

     

    Could you please tell me how many patients have been treated in the past 4 months with the following drugs:

    Please see below data provided for drugs issued from pharmacy.  Pharmacy department do not know the indication that the drugs were prescribed for or whether they were administered.

    • Erenumab (Aimovig) – for any disease - Nil
    • Fremanezumab (Ajovy) – for any disease  - Nil
    • Galcanezumab (Emgality) – for any disease - Nil
    • Botulinum Toxin (i.e., Botox, Dysport, Xeomin) – for migraine ONLY – 66 (As above, pharmacy data does not show the indication for the issue, therefore this data is for all indications, not for migraine only)